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Abstract
Background: A delay presentation for human immunodeficiency virus (HIV) patient’s care (that is late engagement
to HIV care due to delayed HIV testing or delayed linkage for HIV care after the diagnosis of HIV positive) is a critical
step in the series of HIV patient care continuum. In Ethiopia, delayed presentation (DP) for HIV care among vulnerable
groups such as tuberculosis (Tb) /HIV co-infected patients has not been assessed. We aimed to assess the
prevalence of and factors associated with DP (CD4 < 200 cells/μl at first visit) among Tb/HIV co-infected patients in
southwest Ethiopia.
Methods: A retrospective observational cohort study collated Tb/HIV data from Jimma University Teaching Hospital for
the period of September 2010 and August 2012. The data analysis used logistic regression model at P value of ≤ 0.05
in the final model.
Results: The prevalence of DP among Tb/HIV co-infected patients was 59.9 %. Tb/HIV co-infected patients who had a
house with at least two rooms were less likely (AOR, 0.5; 95 % CI: 0.3–1.0) to present late than those having only single
room. Tobacco non-users of Tb/HIV co-infected participants were also 50 % less likely (AOR, 0.5; 95 % CI: 0.3–0.8)
to present late for HIV care compared to tobacco users. The relative odds of DP among Tb/HIV co-infected
patients with ambulatory (AOR, 1.8; 95 % CI, 1.0–3.1) and bedridden (AOR, 8.3; 95 % CI, 2.8–25.1) functional status
was higher than with working status.
Conclusions: Three out of five Tb/HIV co-infected patients presented late for HIV care. Higher proportions of DP
were observed in bedridden patients, tobacco smokers, and those who had a single room residence. These findings
have intervention implications and call for effective management strategies for Tb/HIV co-infection including early HIV
diagnosis and early linkage to HIV care services.
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Background
HIV care continuum is a series of steps from the time a
person is diagnosed with HIV through assessment for
antiretroviral therapy (ART) eligibility, retention in care,
and immunologic success and virologic suppression via
treatment adherence [1]. A myriad of activities have
been devoted to mitigate negative HIV outcomes in the
continuum [2]. Nevertheless, challenges exist at every
step of the continuum. Timely HIV testing is the first
critical step in effective HIV care and prevention [3].
HIV infected persons fail to get tested due to various
factors. Thus include: being unaware of their risk of con-
tracting infection or importance of getting oneself tested
and not being able to access care promptly once they
test positive [4, 5]. Hence, delayed presentation for HIV
care (DP) can either be due to delay in HIV testing or
delay in linkage with or in accessing the HIV care.
There is little consensus on what should be consid-
ered DP, and several definitions have been used to date.
Some have defined DP when the diagnosis of an AIDS
defining condition occurs either before or concomi-
tantly to an HIV diagnosis [6], during the subsequent
six months [5, 7] or during the following year of an
HIV diagnosis [8]. Other definitions of DP use CD4 cell
count of < 200 [9] or < 350 [10] cells/μl. The 1993
expanded AIDS surveillance case definition measured
DP if persons present with a CD4 cell count < 200
cells/μl and/or with an AIDS defining disease [11].
DP has several consequences including: (i) increased
risk of progression of the infection; ii) increased risk of
HIV transmission with severe public health implications
[12]; iii) facilitation of immunological failure and treat-
ment failure [13–15]; (iv) increased risk of poor treat-
ment outcomes including early mortality [13–16]; and v)
increased first line ART drug resistance due to multipli-
cation and then mutation of the virus, and thereby
switching to more expensive second line regimens [12].
In addition, DP also challenges the effectiveness of test-
and-treat strategies [17]. Test-and-treat strategies for
HIV care theorize that earlier testing and treatment of
HIV infection could switch prominently with signifi-
cantly ongoing HIV transmission and further curtail the
HIV epidemic [17].
DP has been reported to be a significant problem
across the world in developed and developing countries.
In Europe for example, the prevalence of DP has been
reported to be roughly between 15 and 66 % [18, 19].
Higher prevalence of 72–83.3 % [20, 21] has been
reported from Asia. In Africa, 35–65 % report late for
HIV care [22–25]. Reported barriers to DP among gen-
eral population have include several factors including:
age, sex, level of education, income, place of residence,
perceiving HIV as curable, HIV related stigma, co-
morbidity, having contact with female sex workers,
alcohol users, chewing chat, smoking cigarette, per-
ceived risky sexual behaviour, pre-and post-test coun-
seling [4, 15, 20, 21, 26, 27].
While there have been no appropriate studies to esti-
mate the prevalence of DP in Ethiopia, a situational ana-
lysis conducted in southwest part of the country reported
that 33.1 % of patients from a health center and 38.4 % of
patients from a hospital presented late for the care [28]. A
few studies have assessed reasons for DP among the gen-
eral HIV population [4, 15, 27]. However, there is a lack of
studies that have explored DP among vulnerable groups
such as tuberculosis (Tb) /HIV co-infected patients.
Tb and HIV, the most important infectious diseases
of our era, are inextricably linked [29]. HIV-1 and
Mycobacterium tuberculosis (M.Tb) are both intracel-
lular pathogens having a potential to interact at differ-
ent levels such as population, clinical, and cellular
[30]. Their co-infection causes serious bidirectional
effect than one causes alone [30]. Both cause synergis-
tic combination of illness in which HIV promotes the
progression of latent Tb infection to disease, and Tb
accelerates the progression of HIV disease to poor
prognosis including death [31]. In addition, HIV has
been ascribed as the principal factor for failure to meet
Tb control targets in HIV endemic settings, and Tb is
a key cause of death among people living with HIV in
similar settings [32]. Given the above facts, DP among
Tb/HIV co-infected patients should be given a top pri-
ority in order to curb both scourges. This study aimed
to assess the prevalence of and factors associated with
DP among Tb/HIV co-infected patients.
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Methods
Design and population
A retrospective observational cohort study was under-
taken between August and October 2013 using records
from September 01, 2010 to August 31 2012 in ART
clinic at Jimma University Teaching Hospital (JUTH).
JUTH is situated in Jimma zone, 357 km southwest of
Addis Ababa, the capital city of Ethiopia. The zone has
an estimated population of 2 486 155 people of which
89.69 % are rural inhabitants [33].
Jimma is found in a regional state (Oromia) that
accounted for the highest number of HIV infected
people from Ethiopia with 224 000 people. It is near
Gambella region, a regional state that had the highest
prevalence rate of HIV from Ethiopia with 6 % [34].
There is a large refugee camp near Jimma. Refugees
from many African countries pour into this camp. The
movement of these people to and from the city increases
the risk of HIV infection and Tb in both the city and the
camp. In Jimma, primary healthcare services, including
diagnosis and treatment of Tb, voluntary counseling
and testing (VCT), prevention of mother to child trans-
mission (PMTCT), ART and opportunistic infections
(OIs) treatment services are available. All patients aged
≥15 years and who had access to Tb/HIV medical treat-
ment at JUTH were the target population.
Data source
JUTH has an electronic patient database called Com-
prehensive Care Centre Patient Application Database
(C-PAD). C-PAD is Electronic Medical Records or
EMR system database that contains patients’ both clin-
ical and non-clinical information. This was the main
source of data in this study. Data were extracted using
a data extraction check list from the database. Data
clerks immediately informed the clinicians if any data
was missing, and weekly EMR-generated patient sum-
mary reports help to flag patients with conditions that
needed follow-up. When data were incomplete, we tried
to refer the patients’ cards, registration and log books.
Study variables
Delayed presentation for HIV care is the response vari-
able and was dichotomized as delayed and early. DP re-
fers to HIV positive individuals aged 15 years and
above having the CD4 lymphocyte count of less than
200/μl irrespective of clinical staging at the time of first
presentation to the ART clinics of the institution. Early
presentation for HIV care refers to HIV positive indi-
viduals aged 15 years and above having the CD4
lymphocyte count of ≥ 200/μl irrespective of clinical
staging at the time of first presentation to the ART
clinics of the institution.
The explanatory variables included age, sex, educa-
tional level, marital status, occupation, residence, num-
ber of people living in the household, accessibility to
safe water, accessibility of electricity, number of bed-
rooms in the household, functional status, disclosure,
condom use, risky sexual behavior, tobacco smoking,
alcohol drinking, Tb type and mode of entry. Level of
education was classified as illiterate (could not read and
write), read and write only (could read and write but
had received no formal education) and formal educa-
tion (received formal education starting from grade
one). Functional status was categorized as work (able to
perform usual work), ambulatory (able to perform
activity of daily living) and bedridden (not able to per-
form activity of daily living). Mode of entry was the
mode of anti-Tb treatment entry of patients and was
categorized as new, relapse and dropout.
Data analyses
Data exploration, editing and cleaning were undertaken
before analysis. The analysis of both descriptive and
inferential statistics was conducted. Descriptive statis-
tics included mean and standard deviation values for
continuous data; percentage and frequency tables for
categorical data. Logistic regression was used to identify
factors associated with DP. Bivariate logistic regression
analysis was conducted to see the existence of crude
association and select candidate variables (with P value
below 0.25) to multiple logistic regression. We checked
multi-collinearity among selected independent variables
via variance inflation factor (VIF) and none was found.
P-value ≤ 0.05 was considered as a cut point for statis-
tical significance in the final model. Fitness of goodness of
the final model was checked by Hosmer and Lemeshow
test and was found fit. The data was summarized using
odds ratio (OR) and 95 % confidence interval. Data
analysis was conducted using SPSS version 21 for
mackintosh.
Results
Demographic characteristics of study participants
Two hundred and eighty nine (289) Tb/HIV co-infected
patients were registered for HIV care during the period
between September 2010 and August 2012 in JUTH
(Fig. 1), but 17 records were incomplete in all data
sources. Table 1 shows demographic characteristics of
the 272 Tb/HIV co-infected respondents. The majority
of the study participants were between 25 and 34 years
with a mean age of 32 (±8.53) years, and females
accounted for more than half (58.1 %) of the study par-
ticipants. About half (51.4 %) of the respondents
followed Muslim religion and one third (31.6 %) of par-
ticipants represented daily laborers. More than half of
the population (51.5 %) had formal education and two
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third (60.7 %) of the respondents were married. Urban
dwellers were over-represented (70 %).
Prevalence of delayed presentation for HIV care and
characteristics of delayed presenters
A total of 163 (59.9 %) Tb/HIV co-infected patients were
categorised as delayed presenters for HIV care during
the study period. Table 2 presents demographic and clin-
ical characteristics of DP. Tb/HIV participants aged
between 25 and 34 years, and 35 and 44 years contrib-
uted for 46.6 % and 28.2 % of DP proportion respect-
ively. Females accounted for more than half (55.8 %) of
DP. DP was also higher among married (61.3 %) com-
pared to single (20.9 %) study participants. DP was very
high among occupants with economic hardship. Farmers
and daily laborers formed 32.5 and 27 % of DP amongst
the study participants respectively. When analyzed by
level of education, about half (48.5 %) of the participants
who presented late for HIV care were formally educated
whereas one third (30.1 %) were illiterate. The remaining
delayed presenters were noted as being able to read and
write but did not have formal education. Two third
(66.9 %) of delayed presenters were urban dwellers.
Among the delayed presenters, 77 (47.2) and 55 (33.7 %)
study participants had houses with single and double
bedrooms respectively; whereas households with four
bedrooms accounted for only 4.9 % of delayed pre-
senters. A fifth, i.e. 20.2 and 21.5 % of delayed pre-
senters did not have water and electricity in their
households. An additional 21.5 % of delayed presenters
were seriously ill and bedridden. The majority (75.5 %)
of delayed presenters had pulmonary Tb type followed
by mixed type (19 %). Tb/HIV participants who were
exposed to risky behaviors such as having multiple sex-
ual partners accounted for 69.3 % of DP.
Factors associated with delayed presentation for HIV care
Age, occupational status, place of residence, number of
rooms per household, availability of safe water, smoking
tobacco and functional status had P-value ≤ 0.25 in
bivariate logistic regression and were candidates for mul-
tiple logistic regression (Table 2).
Table 3 presents the multiple logistic regression ana-
lysis with DP. Logistic regression analyses demonstrated
the following were associated with DP: number of rooms
per household, being recorded as tobacco user and
being recorded as ambulatory or bedridden functional
status. Tb/HIV co-infected patients who had houses
with double rooms were less likely (AOR, 0.5; 95 % CI:
0.3–1.0) to present late than those having only single
room. Tobacco non-users of Tb/HIV co-infected partic-
ipants were also 50 % less likely (AOR, 0.5; 95 % CI:
0.3–0.8) to present late for HIV care compared to to-
bacco users. The relative odds of DP among patients
with working status was lower compared to patients
with bedridden (AOR, 8.3; 95 % CI, 2.8–25.1) and am-
bulatory (AOR, 1.8; 95 % CI, 1.0–3.1) status.
Discussion
The UNAIDS 90-90-90 goal for 2020 aims to of diag-
nose 90 % of people living with HIV, provide antiretro-
viral therapy (ART) to 90 % of those diagnosed and
achieve 90 % viral load suppression among those on
treatment [35]. The trend of expansion of HIV care ser-
vices particularly ART treatment in Ethiopia is promis-
ing. ART program was expanded from four facilities in
2003 to 913 in 2013, and the number of people on ART
Late: 163
Population Defined
289 records of Tb/HIV Co-infected 
patients from 2010-2012
272 records of Tb/HIV Co-infected 
patients were complete for analysis
17 incomplete records
Early: 109
Fig. 1 Schematic presentation of data extraction of delayed presentation for HIV care among Tb/HIV co-infected patients
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has increased from 900 at the beginning of 2005 to
270,460 in 2012 [36, 37]. However, not much attention
has been given to prevent DP for the vulnerable groups
particularly Tb/HIV co-infected patients which remains
one of the vastest defies in the reduction of HIV infec-
tion in resource scare countries including Ethiopia.
Nearly 60 % of the patients in our study were delayed
presenters, a finding that is similar with a study con-
ducted in Zimbabwe [38]. This is also a comparable
magnitude with DP of general HIV population in Africa
[22, 26].
However, in Ethiopia, the prevalence of DP among
TB/HIV co-infected patients according to the current
study is about twice as compared to the previous find-
ing conducted among general HIV population [4]. This
indicates that the prevalence of DP among Tb/HIV co-
infected patients is a considerable number. This is
against the current treatment guidelines of WHO and
Ethiopia that advocate early commencement of ART
among Tb/HIV co-infected patients [32, 39, 40]. Such
an impediment to engage for HIV care poses a sizeable
obstacle to the successful implementation of strat-
egies that suggest “test” (i.e. early identification of
all HIV-infected individuals) and “treat” (i.e. initi-
ation of antiretroviral therapy in these individuals)
[41–43]. Previous studies confirmed that “test” and
“treat” strategy could have dramatic reductions in
the incidence of HIV infection and transmission
[41–43].
The timing of ART treatment initiation among Tb/HIV
co-infected patients is critically important for the favor-
able therapeutic outcomes and patient care [39].
According to the current guidelines, ART should be
started within 2–8 weeks after commencement of anti-
Tb treatment [44]. Nevertheless, the issue of when to
start ART in Tb patients has been debatable [45, 46].
Early or concurrent starting of ART may lead to high
pill burden, clinical debilitation due to immune recon-
stitution inflammatory syndrome (IRIS), toxicity of
drugs, decrease drug compliance, worsening of ailment,
and finally demise [45, 46]. To the contrary, late com-
mencement of ART may lead to exacerbation of ail-
ment and death [45, 46].
Findings of a previous study conducted in Zimbabwe
[38] depicted that being treated for Tb first time, staying
more than 5 km from a clinic, and having a family mem-
ber on ART were factors for delayed ART initiation. In
addition, findings of another study from Malawi [47]
revealed that cost of transport to the hospital ART site
was significantly associated with ART acceptance. This in-
dicates that ART acceptance among Tb patients in a rural
district in Malawi is low and may engage to care late.
In the current finding, DPs were more likely to be to-
bacco smokers and debilitated patients from households
with one room. The high probability of DP in tobacco
smokers might plausibly be associated with the effect of
smoking on Tb treatment outcome. A prospective co-
hort from Jordan reported that the risk of a poor Tb
treatment outcome was much higher (70 %) in current
smokers compared to never smokers [48]. Such a co-
incidence of smoking and poor Tb treatment outcome
might affect timely HIV care presentation. The potential
of smoking to induce coughing and other symptoms
consistent with tuberculosis may delay Tb diagnosis
among smokers than non-smokers and this may prohibit
to seek health care services as result of poor Tb progno-
sis that caused by delayed diagnosis [49]. Findings of our
current study also support this in which the likelihood
of bedridden patients to DP was higher than working
patients.
For the above reasons, Tb experts declare “Clearing the
smoke around the Tb/HIV Syndemic” [50]. In addition,
Table 1 Demographic characteristics of Tb/HIV co-infected
patients at JUTH, Southwest Ethiopia, 2013
Variable Category Number (n = 272) Percent
Age (in years) 15–24 38 13.9
25–34 140 51.5
35–44 69 25.4
≥ 45 25 9.2
Mean age (± SD) 32 (±8.53) years
Sex Male 114 41.9
Female 158 58.1
Occupation Government employed 48 17.7
NGO 46 16.9
Farmer 80 29.4
Daily labor 86 31.6
Female Sex Worker 12 4.4
Educational status Illiterate 81 29.8
Read & write (informal) 51 18.8
Formal education 140 51.4








Residence Urban 189 69.5
Rural 83 30.5
Tb/HIV tuberculosis/human immunodeficiency virus, JUTH Jimma University
Teaching Hospital, NGO Non Governmental Organization, SD
standard deviation
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Table 2 Demographic, clinical and behavioral characteristics of Tb/HIV co-infected patients by time to presentation for HIV care at
JUTH, Southwest Ethiopia, 2013
Variable Category Time to present for HIV care COR (95 % CI)
Early, n (%) Late, n (%)
Agea < 25 years 15 (13.8) 23 (14.1) 1
25–34 years 64 (58.7) 76 (46.6) 0.8 (0.4–1.6)
35–44 years 23 (21.1) 46 (28.2) 1.3 (0.6–2.9)
≥ 45 years 7 (6.4) 18 (11.1) 1.7 (0.6–4.9)
Sex Male 42 (38.5) 72 (44.2) 1
Female 67 (61.5) 91 (55.8) 0.8 (0.5–1.3)
Marital status Single 24 (22) 34 (20.9) 1
Married 65 (59.6) 100 (61.3) 1.1 (0.6–2.0)
Divorced 13 (11.9) 23 (14.1) 1.3 (0.5–2.9)
Widowed 7 (6.4) 6 (3.7) 0.6 (0.2–2.0)
Education Illiterate 32 (29.4) 49 (30.1) 1
Read and Write 16 (14.7) 35 (21.5) 1.4 (0.7–3.0)
Formal Education 61 (56) 79 (48.5) 0.9 (0.5–1.5)
Occupationa Government Employee 21 (19.3) 27 (16.6) 1
NGO 14 (12.8) 32 (19.6) 1.8 (0.8–4.2)
Farmer 27 (24.8) 53 (32.5) 1.5 (0.8–3.2)
Daily Labor 42 (38.5) 44 (27) 0.8 (0.4–1.6)
FSW 5 (4.6) 7 (4.3) 1.1 (0.3–3.9)
Residencea Urban 80 (73.4) 109 (66.9) 1
Rural 29 (26.6) 54 (33.1) 1.4 (0.8–2.3)
Number of roomsa 1 44 (40.4) 77 (47.2) 1
2 55 (50.5) 55 (33.7) 0.6 (0.3–0.9)
3 8 (7.3) 23 (14.1) 1.6 (0.7–3.9)
4 2 (1.8) 8 (4.9) 2.3 (0.5–11.2)
Watera,b Yes 77 (70.6) 130 (79.8) 1
No 32 (29.4) 33 (20.2) 0.6 (0.4–1.1)
Electricity Yes 79 (72.5) 128 (78.5) 1
No 30 (27.5) 35 (21.5) 0.7 (0.4–1.3)
Disclosure Yes 67 (61.5) 109 (66.9) 1
No 42 (38.5) 54 (33.1) 1.3 (0.8–2.1)
Partner’s HIV Status Positive 72 (66.1) 117 (71.8) 1
Negative/Unknown 37 (33.9) 46 (28.2) 0.8 (0.5–1.3)
Risky Behavior Yes 78 (71.6) 113 (69.3) 1
No 31 (28.4) 50 (30.7) 1.1 (0.7–1.9)
Condom Use Yes 14 (12.8) 33 (20.2) 1
No 95 (87.2) 130 (79.8) 0.6 (0.3–1.2)
Tobacco usea Yes 40 (36.7) 86 (52.8) 1
No 69 (63.3) 77 (47.2) 0.5 (0.3–0.9)
Drinking alcohol Yes 29 (26.6) 47 (28.8) 1
No (80 73.4) 116 (71.2) 0.9 (0.5–1.5)
Functional statusa Work 68 (62.4) 70 (42.9) 1
Ambulatory 37 (33.9) 58 (35.6) 1.5 (0.9–2.6)
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the current finding may also call for designing and includ-
ing strategies in the routine program to reduce tobacco
among Tb/HIV co-infected patients [51]. In support of
this, The Center for Disease Control (CDC) also calls for
prompt action to incorporate anti-smoking strategies into
Tb, HIV, and Tb-HIV care, and advise to apply the World
Health Organization’s MPOWER [52] strategy for lessen-
ing tobacco use [51]. This is critical issue for Tb and HIV
treatment and care in contributing not only for earlier
presentation for HIV care but also for developing good
prognosis after linking the care [50]. However, we also ad-
vised further study to explore the association between
smoking and time to present for HIV care among the
population.
Bedridden patients had eight times (AOR = 8.3, 95 %
CI: 2.8–25.1) increased risk of DP than patients recorded
as being in working status. These findings do not come
as a surprise because patients who are bedridden have
probably been exposed to more infections and have
poorer health outcomes, a barrier that hinders early
presentation for HIV care [50, 53]. It is thus plausible to
suggest routine opportunistic infections and other dis-
eases screening in patients with Tb or HIV in order to
establish early and effective management strategies to
reduce preventable mortalities from these conditions. In
addition, HIV screening in general population, and home
based HIV testing and linking to care should also be
strengthened.
Tb/HIV patients from household with two or more
rooms had 50 % lesser risk (AOR = 0.5, 95 % CI: 0.3–0.8)
to DP than owning a single room. This demonstrated
the role of adequate housing as an important enabler of
effective care at steps of HIV care continuum. It is up on
this intention that the U.S. Department of Housing and
Urban Development (HUD) established the Housing
Opportunities for Persons With AIDS (HOPWA) pro-
gram and had a bold impact in the HIV Care Con-
tinuum Initiative [3]. The inadequacy in housing can
lead to overcrowding that worsens Tb conditions in
poor settings and this may deter HIV care use. This is
supported by the current findings that significant pro-
portion (61.3 %) of DP participants in the current study
lived with more than five individuals in a single house.
These factors have also been supported by several stud-
ies conducted across the globe [54–56]. This cues the
need of revising intervention framework of Tb/HIV
care that was focused on health sector alone. Efforts
should be made to integrate and improve prevailing
Table 2 Demographic, clinical and behavioral characteristics of Tb/HIV co-infected patients by time to presentation for HIV care at
JUTH, Southwest Ethiopia, 2013 (Continued)
Bedridden 4 (3.7) 35 (21.5) 8.5 (2.9–25.2)
Tb Type Pulmonary 90 (82.6) 123 (75.5) 1
Extra Pulmonary 5 (4.6) 9 (5.5) 1.3 (0.4–4.1)
Mixed 14 (12.8) 31 (19) 1.6 (0.8–3.2)
Mode of Tb treatment Entry New 91 (83.5) 141 (86.5) 1
Relapse 11 (10.1) 16 (9.8) 0.9 (0.4–2.1)
Dropout 7 (6.4) 6 (3.7) 0.6 (0.2–1.7)
HIV human immunodeficiency virus, JUTH Jimma University Teaching Hospital, Tb tuberculosis, FSW female sex workers
aCandidate variables for multiple logistic regression (P-value < 0.25)
bAvailability of safe water
Table 3 Multiple logistic regression predictors of delayed presentation for HIV care at JUTH, Southwest Ethiopia, 2013
Variable Category Time to present for HIV care (n = 272) Odds Ratio
Early, n (%) Late, n (%) Crude OR (95%CI) Adjusted OR (95 % CI)
Number of rooms 1 44 (40.4) 77 (47.2) 1 1
2 55 (50.5) 55 (33.7) 0.6 (0.3–0.9) 0.5 (0.3–1.0)*
3 8 (7.3) 23 (14.1) 1.6 (0.7–3.9) 1.7 (0.7–4.4)
4 2 (1.8) 8 (4.9) 2.3 (0.5–11.2) 1.7 (0.3–8.9)
Tobacco use Yes 154 (81.5) 35 (18.5) 1 1
No 63 (75.9) 20 (24.1) 1.4 (0.8–2.6) 0.5 (0.3–0.8)*
Functional status Work 68 (62.4) 70 (42.9) 1 1
Ambulatory 37 (33.9) 58 (35.6) 1.8 (1.0–3.1) 1.8 (1.0–3.1)*
Bedridden 4 (3.7) 35 (21.5) 2.2 (0.9–4.7) 8.3 (2.8–25.1)*
JUTH Jimma University Teaching Hospital, OR odds ratio, CI confidence interval
*Denotes statistically significant in final model at P value of ≤ 0.05 in the final model
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social determinants particularly housing in the manage-
ment of HIV/Tb co-infection [29].
The study has the following limitations that should
be acknowledged. Firstly, there were incomplete data
and small sample size. This may have affected the pre-
cision of the estimates. Secondly, variables that could
potentially have major contribution and confounding
effect (e.g. HIV related stigma) were not assessed.
Thirdly, due to inadequate data of desired variables, the
prevalence of DP was not further described by delayed
HIV testing and delayed ART initiation after early HIV
testing. Fourthly, the proportion of DP is also not de-
scribed by the timing of Tb diagnosis so that the effect
of early or late Tb diagnosis would have been hypothe-
sized. Fifthly, assessment of the effect of Tb treatment
outcomes- default, lost to follow up, failure or cure- on
time to present for HIV care is beyond the scope of the
current study. Lastly, a gold standard measure of DP
for resource limited countries is not yet established. As
Collaboration of Observational HIV Epidemiological
Research Europe (COHERE) group set definition of DP
for the population of Europe [57], research groups in
Africa should also set the ‘gold standard’ definition of DP
for HIV care among general adult HIV positive popula-
tion, HIV positive children, HIV positive mothers and
Tb/HIV co-infected patients.
Conclusions
The findings of the current study have informed that
three out of five Tb/HIV co-infected patients delayed for
HIV care and delayed presenters were more likely to be
tobacco smokers, bedridden patients and those who
were from households with single bedroom. The exist-
ence of high DP among Tb/HIV co-infected cases needs
actions to reduce the aforementioned risk factors. The
findings of the current study have policy and practice
implications and they call for effective management
strategies for Tb/HIV co-infection including improved
availability of early diagnosis and improved availability of
ARVs. Such study should also be followed by further re-
search to assess barriers of DP among other vulnerable
groups such as children and mothers, and other key
population.
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